跳至主要内容
临床试验/NCT07094945
NCT07094945尚未招募4 期

The Effect of Remimazolam on Postoperative Sleep Quality of Patients Undergoing Gynecological Day Surgery

Tongji Hospital0 个研究点目标入组 260 人开始时间: 2025年8月15日最近更新:
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
260
主要终点
Richard Campbell's Sleep Scale score

研究概览

简要总结

A large amount of clinical evidence shows that after surgery, especially major surgery, the sleep quality of patients often drops significantly immediately, with the most obvious decline on the first night after surgery, which can last for several days to several months. Remimazolam is a new type of benzodiazepine drug and a super-short-acting GABAA receptor agonist. Compared with propofol, remimazolam can largely avoid adverse reactions such as hemodynamic fluctuations, excessive sedation and injection pain caused by propofol. It has good safety and is superior to propofol. However, there are currently only a few clinical research results regarding the impact of remimazolam on the sleep quality of patients under general anesthesia or sedation. Therefore, this study intends to observe the effect of remimazolam on the sleep quality of patients in gynecological day surgery. It is expected that by optimizing the anesthesia plan, the postoperative sleep quality of patients can be improved, and ultimately the postoperative recovery of patients can be promoted.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA classification grades I - II.
  • BMI: 18.5-24 kg/m ².
  • Be able to correctly understand and complete the assessment scale independently.
  • The operation time shall not exceed one hour.
  • Informed consent for this research.

排除标准

  • PSQI > 7 points (with sleep disorders requiring medical intervention within the last month).
  • Suffering from central nervous system diseases or mental disorders.
  • Patients with sleep apnea syndrome or other serious respiratory diseases.
  • Have functional disorders of important organs.
  • Alcohol abuse or a history of opioid, benzodiazepine or other known drug abuse that may affect sleep.
  • Allergic to the research medication.

研究组 & 干预措施

Remimazolam Grop

Experimental

Remimazolam 0.3mg/kg for induction and 0.6-1.0 mg/kg·h for maintenance of anesthesia

干预措施: Remimazolam (Drug)

Propofol Group

Active Comparator

Propofol 2 mg/kg for induction and 4-12 mg/kg·h for maintenance of anesthesia

干预措施: Propofol (Drug)

结局指标

主要结局

Richard Campbell's Sleep Scale score

时间窗: The night of the first to third postoperative day

Range: 0 points (optimal sleep) to 10 points (optimal sleep). Direction: The higher the score, the more severe the sleep problem

次要结局

  • Blood Pressure(Before anesthesia, before the insertion of the laryngeal mask, at the beginning of the operation, at the end of the operation, and when the laryngeal mask is removed)
  • Heart rate(Before anesthesia, before the insertion of the laryngeal mask, at the beginning of the operation, at the end of the operation, and when the laryngeal mask is removed.)
  • Postoperative adverse reactions(24 hours after the operation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Feng Gao

Professor

Tongji Hospital

相似试验

The Effect of Remimazolam on Postoperative Sleep... | 临床试验